OctariusRx
FEBRUARY 20, 2023
The 2023 controlled substance assessment quiz is about to be released! This is our first annual competency assessment focused on controlled substances and regulatory compliance. The quiz focuses on some of the basic elements managing controlled substances. How are you assessing your staff?
The FDA Law Blog
FEBRUARY 28, 2023
Houck — The Drug Enforcement Administration’s (“DEA’s”) February 13th determination that THC acetate ester (“THCO”) is a schedule I controlled substance under the federal Controlled Substances Act (“CSA”) has received a good amount of attention in the cannabis press. 13, 2023). By Larry K. Terrence L. Boos, Ph.D.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
OctariusRx
NOVEMBER 20, 2023
The 2023 version of the OctariusRx USP 800 assessment quiz is about to be released! With the enforcement of USP Chapter 800 beginning on November 1, 2023, facilities will be required to assess staff competency on an annual basis. The post The 2023 USP 800 Assessment Quiz appeared first on OctariusRX. Contact us for assistance.
The FDA Law Blog
AUGUST 21, 2023
Attorney’s Office for the Western District of Texas announced that People’s Rx, a local chain operating five retail pharmacies and a compounding laboratory in the Austin area, agreed to pay $200,000 to settle allegations that it violated the Controlled Substances Act (“CSA”). 16, 2023 ( DOJ Press Release ).
The Checkup by Singlecare
MARCH 23, 2023
Understanding the difference between CBD vs. marijuana Cannabinoids are compounds found in the cannabis plant, Cannabis sativa. The United States Congress legalized CBD derived from hemp in 2018 when the Agricultural Improvement Act was signed into law, removing hemp from the Federal Controlled Substances Act.
The Checkup by Singlecare
OCTOBER 25, 2023
a compounding pharmacist at Pharmedico in Sarasota, Florida. Meloxicam is not a controlled substance. It is not considered addictive in the same way as substances like opioids or certain recreational drugs. It is in the same drug class as ibuprofen , aspirin , naproxen , and diclofenac. appeared first on The Checkup.
The FDA Law Blog
JANUARY 18, 2024
Houck — In August 2023 the Food and Drug Administration (“FDA”) and Health and Human Services (“HHS”) recommended that the Drug Enforcement Administration (“DEA”) reschedule marijuana from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. By Larry K.
Expert insights. Personalized for you.
75 
Let's personalize your content